Your session is about to expire
← Back to Search
Electronic Decision Support Tool
MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study) (E-CARE Trial)
N/A
Waitlist Available
Led By Emily McDonald, MDCM
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial tests an electronic tool called MedSafer, which helps doctors and nurses in aged care facilities safely reduce or stop unnecessary medications for older adults. The tool analyzes patient information and provides real-time reports on which medications can be safely adjusted. This helps healthcare providers manage complex medication regimens more effectively.
Eligible Conditions
- Deprescribing
- Overmedication
- Adverse Drug Reactions
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion of patients with one or more PIM (potentially inappropriate medication) reduced or stopped
Secondary study objectives
Sustainability; quality of life; sleep quality; falls; transfer to acute hospital; hip fractures; and delirium
Other study objectives
Cost savings
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention: MedSaferExperimental Treatment1 Intervention
In the intervention phase, the MedSafer feature will become accessible in MED e-care for the physicians, pharmacists and nurses. This feature will provide health care professionals with individualized and prioritized deprescribing opportunities: a) identifying the medication, b) explaining why that medication is potentially inappropriate and c) providing instructions on how to safely stop/taper the medication. The user will review these opportunities and appropriate candidate medications for deprescribing can then be tapered or stopped directly in the EMR. During the intervention phase, all patients will receive the educational (EMPOWER) brochures as applicable to the medications they are taking (PPI, sedative-hypnotic, antihistamine, antipsychotic, sulfonylurea, NSAID, opioid/narcotic).
Group II: Control: Baseline (no MedSafer)Active Control1 Intervention
During the control phase, the MedSafer application programming interface will not be accessible to the caretakers at the aged care facilities (ACF). This serves to obtain baseline deprescribing levels for each ACF.
Find a Location
Who is running the clinical trial?
Centre for Aging and Brain Health InnovationOTHER
15 Previous Clinical Trials
5,200 Total Patients Enrolled
OMNI Health CareUNKNOWN
MED e-care Healthcare SolutionsUNKNOWN
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
470 Previous Clinical Trials
166,944 Total Patients Enrolled
1 Trials studying Deprescribing
1,000 Patients Enrolled for Deprescribing
Emily McDonald, MDCMPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre